Skip to main content

UBS Group AG

Position in PYXS — Pyxis Oncology, Inc.

CIK 1610520 ZURICH, V8

Position in PYXS

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$371,021
-$80,659 QoQ
Shares Held
254,124
-35.3% QoQ
Ownership
0.401%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 78 holders
Holding Since
Dec 2021
17 quarters on record
Voting authority Sole 98.8981756937558.ToString("F0")% Shared 0.ToString("F0")% None 1.101824306244196.ToString("F0")%

Common Shares in PYXS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,296,969,172 across 554 Biotechnology names. PYXS ranks #299 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PYXS

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $371,021 254,124
2025-12-31 $451,680 392,766
2025-09-30 $829,673 373,727
2025-06-30 $435,705 396,096
2025-03-31 $388,906 396,844
2024-12-31 $696,849 446,699
2024-09-30 $103,134 28,102
2024-06-30 $58,514 17,678
2024-03-31 $120,345 28,250
2023-12-31 $5,319 2,955
2023-09-30 $5,880 2,955
2023-06-30 $19,583 7,650
2023-03-31 $11,849 2,955
2022-09-30 $305 155
2022-06-30 $873 367
2022-03-31 $5,785 1,432
2021-12-31 $52,853 4,818